Ionis, AstraZeneca To Use Real-World Data To Accelerate RNA-Targeting Cholesterol Drug

Phase I Shows Promise, But ION449 Must Catch Up With Inclisiran

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.